Acutus Medical Inc [AFIB] stock prices are up 6.53% to $0.17 at the moment. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The AFIB shares have lost -1.25% over the last week, with a monthly amount drifted -8.73%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Acutus Medical Inc [NASDAQ: AFIB] stock has seen the most recent analyst activity on November 15, 2021, when JP Morgan downgraded its rating to a Underweight. Previously, Goldman started tracking the stock with Neutral rating on October 22, 2021, and set its price target to $10. On July 15, 2021, upgrade upgraded it’s rating to Buy and revised its price target to $18 on the stock. William Blair downgraded its rating to a Mkt Perform and decreased its price target to $19 on March 19, 2021. JP Morgan downgraded its rating to a Neutral and reduced its price target to $19 on March 19, 2021. BofA Securities downgraded its rating to Neutral for this stock on January 14, 2021, and downed its price target to $30. In a note dated August 31, 2020, William Blair initiated an Outperform rating.
The stock price of Acutus Medical Inc [AFIB] has been fluctuating between $0.16 and $1.09 over the past year. Currently, Wall Street analysts expect the stock to reach $1.5 within the next 12 months. Acutus Medical Inc [NASDAQ: AFIB] shares were valued at $0.17 at the most recent close of the market. An investor can expect a potential return of 782.35% based on the average AFIB price forecast.
Analyzing the AFIB fundamentals
The Acutus Medical Inc [NASDAQ:AFIB] reported sales of 19.66M for trailing twelve months, representing a surge of 43.74%. Gross Profit Margin for this corporation currently stands at -0.44% with Operating Profit Margin at -1.64%, Pretax Profit Margin comes in at -1.65%, and Net Profit Margin reading is -11.44%. To continue investigating profitability, this company’s Return on Assets is posted at -1.52, Equity is -2.43 and Total Capital is -0.33. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-43.78.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.1623 points at the first support level, and at 0.1501 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.1875, and for the 2nd resistance point, it is at 0.2005.
Ratios To Look Out For
It’s worth pointing out that Acutus Medical Inc [NASDAQ:AFIB]’s Current Ratio is 4.92. Further, the Quick Ratio stands at 3.85, while the Cash Ratio is 1.01. Considering the valuation of this stock, the price to sales ratio is 0.26, the price to book ratio is 0.16.
